Tag: Anti tnf

For up to 40% of Crohn's disease patients, anti-TNF biologics either fail to work initially or lose their effectiveness over time. This can be a discouraging setback, leaving many to wonder **what happens if biologics don't work for Crohn's** and what their next options are.

Affecting up to 5% of the general population, frozen shoulder is a painful and debilitating condition. While there is no single new drug for frozen shoulder currently available, researchers are investigating novel therapies, including biological agents like adalimumab, to better target the underlying causes of the condition.